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Incorporation of self-derived CRISPR DNA protospacers in Campylobacter jejuni PT14
occurs in the presence of bacteriophages encoding a CRISPR-like Cas4 protein. This
phenomenon was evident in carrier state infections where both bacteriophages and
host are maintained for seemingly indefinite periods as stable populations following
serial passage. Carrier state cultures of C. jejuni PT14 have greater aerotolerance in
nutrient limited conditions, and may have arisen as an evolutionary response to selective
pressures imposed during periods in the extra-intestinal environment. A consequence
of this is that bacteriophage and host remain associated and able to survive transition
periods where the chances of replicative success are greatly diminished. The majority
of the bacteriophage population do not commit to lytic infection, and conversely the
bacterial population tolerates low-level bacteriophage replication. We recently examined
the effects of Campylobacter bacteriophage/C. jejuni PT14 CRISPR spacer acquisition
using deep sequencing strategies of DNA and RNA-Seq to analyze carrier state cultures.
This approach identified de novo spacer acquisition in C. jejuni PT14 associated with
Class III Campylobacter phages CP8/CP30A but spacer acquisition was oriented toward
the capture of host DNA. In the absence of bacteriophage predation the CRISPR spacers
in uninfected C. jejuni PT14 cultures remain unchanged. A distinct preference was
observed for incorporation of self-derived protospacers into the third spacer position
of the C. jejuni PT14 CRISPR array, with the first and second spacers remaining fixed.
RNA-Seq also revealed the variation in the synthesis of non-coding RNAs with the
potential to bind bacteriophage genes and/or transcript sequences.
Keywords: CRISPR, ncRNA, campylobacter, bacteriophage, carrier state lifecycle, RNA-Seq
Hooton et al. Campylobacter Bacteriophage Carrier State
INTRODUCTION
The functional role of CRISPR-Cas systems in Bacteria and
Archaea is recognized as providing the benefit of acquired
immunity to the prokaryotic kingdom. In order to counter the
constant threats posed by mobile genetic elements the CRISPR-
Cas system has evolved to survey, acquire, adapt, and destroy
invading DNA in a sequence-specific manner. The invading
elements may be in the form of plasmids or bacteriophages,
which if not dealt with in a timely fashion could lead to
the demise of the infected cell/bacterial population. The major
components found in all CRISPR-Cas systems are the CRISPR-
associated (Cas) proteins, Cas1 DNA endonuclease and Cas2
RNA endonuclease (Koonin and Krupovic, 2015; Selle and
Barrangou, 2015). These proteins operate during the acquisition
stage to generate protospacers (captured DNA) which are
subsequently incorporated into the CRISPR array. Recently,
analysis of mobile genetic elements known as transposons
revealed a possible evolutionary origin for Cas1 protein. Named
casposons, these transposable genetic elements were found to
possess Cas1 DNA endonuclease domains as well as hallmarks
of eukaryotic DNA transposons (B family DNA polymerase
genes and terminal inverted repeats). Integration and excision
of the casposon is proposed to be mediated by the encoded
Cas1 endonuclease domain in a similar manner to how CRISPR
spacer acquisition occurs in prokaryotes (Krupovic et al., 2014).
Transcription of integrated spacers leads to the generation of
CRISPR RNAs (crRNAs) that serve as RNA guides for the
interference step (Hochstrasser and Doudna, 2015). Various
other proteins combine to produce the interference effect, and
the presence or absence of these proteins has allowed the
classification of CRISPR-Cas systems into Type IA-U, Type IIA-
C, Type IIIA-D, Type IV, and Type V (Makarova et al., 2015).
Type II CRISPR-Cas systems have been shown to consist of
several different permutations of genes encoding Cas1, Cas2,
Csn2, Cas4, and Cas9 proteins (Figure 1). These proteins work
in conjunction with trans-activated CRISPR RNAs (tracrRNAs),
which are encoded within the sequence environment adjacent
to the CRISPR array (Jiang and Doudna, 2015). The global
gastrointestinal pathogen Campylobacter jejuni possesses a Type
II-C CRISPR system. A recent survey of the available C. jejuni
genome sequences reported that the Type II-C CRISPR system
was almost universally present, with the exception that it
was absent in representatives of the MLST clonal complex 42
(Pearson et al., 2015). Analysis of the distribution of CRISPR
arrays in C. jejuni (n = 3746) and Campylobacter coli (n =
486) genome sequences indicated that CRISPR systems of C.
coli strains isolated from agricultural environments were more
closely related to those of C. jejuni rather than the CRISPR
system encoded by C. coli isolates of non-agricultural origin.
It is suggested that the shared environmental niche has driven
the acquisition of a specific CRISPR system within and between
circulating C. jejuni and C. coli (Pearson et al., 2015). Due to the
almost ubiquitous distribution of CRISPRs and their associated
genes within C. jejuni it may prove that these systems can be
adopted as a means of typing different strains. However, for C.
coli, the limited distribution of the CRISPR systems would prove
to be a barrier to any successful CRISPR-based typing scheme (de
Cárdenas et al., 2015).
By definition Type II-C CRISPR systems encode Cas1 and
Cas2 nucleases for protospacer acquisition, tracrRNA which acts
as a guide for targeting recognized foreign DNA, and Cas 9
protein which provides the immunity function (Chylinski et al.,
2013; Plagens et al., 2015). The production of antisense CRISPR
RNA requires the presence of host-encoded RNase III in Type
II-C CRISPR systems. Subsequent reinfection events trigger the
RNA-mediated targeting of Cas9 endonuclease to foreign DNA.
This is facilitated by recognition of the dsRNA molecule that
arises following complementary base pairing of tracrRNA to the
3′-end of the processed antisense crRNA (Chylinski et al., 2014).
The discovery of CRISPR-Cas systems has benefitedmolecular
biology and the life sciences tremendously. Targeted genome
editing utilizing CRISPR Cas9-based technologies has led to
a revolution in functional genomics and how genes may be
analyzed (Hsu et al., 2014). Ultimately the development of next
generation technologies may well lead to major breakthroughs
in our understanding of gene expression in health and disease
(Sontheimer and Barrangou, 2015). The ability of Cas9 protein
to introduce double-stranded breaks in target DNA sequences is
a key component of CRISPR-based technologies. The precision
afforded by Cas9-mediated DNA editing has provoked intense
research in the fields of gene therapy (Barrangou, 2015). By
combining Cas9 with a guide RNA, a chimeric RNA molecule
consisting of tracrRNA:CRISPR RNA, it is possible to introduce
breaks in dsDNA molecules in a highly-reproducible precise
manner. DNA cleavage is achieved via the action of two Cas9
nuclease domains (HNH and RuvC-like), and with the aid of
bespoke guide RNA transcripts it was found possible to target any
given DNA sequence (Jinek et al., 2012).
However, functional studies of CRISPR-Cas systems in
prokaryotes suggest there is a degree of complexity as to how they
operate in nature. The evolutionary consequences of possessing
CRISPR-Cas systems have required that both prokaryotes and
phages adopt mechanisms capable of countering the potentially
deleterious effects of CRISPR immunity. Recently it was shown
that within a population of S. epidermidis RP62a, and in the
presence of an invading plasmid, a sub-fraction of the culture
was actively deleting its Type III-A CRISPR system. The obvious
benefit to the mutant population is that it may acquire beneficial
traits associated with the uptake of the plasmid. Conversely,
the population which retains the system would survive plasmid-
invasion by CRISPR-mediated immunity if uptake was proven to
be deleterious (Jiang et al., 2013).
It is becoming evident that the evasion of CRISPR-
mediated immunity is another key mechanism involved in
the phage/bacteria co-evolutionary arms race that should be
added to the established mechanisms including restriction–
modification systems, alteration of outer membrane proteins
countered by changes to adsorption apparatus, and abortive
infection mechanisms (Plagens et al., 2015). For bacteriophages,
the constant selective pressures imposed on their replicative
success drive this evolutionary process, which has resulted in
the emergence of a diverse array of anti-CRISPR mechanisms.
Phage-encoded genes have the ability to inactivate the Type I-E
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FIGURE 1 | Organization of the genomic loci of representative Type II CRISPR-Cas systems. The type II-C arrangement represents the Campylobacter jejuni
carrier state with the addition of bacteriophage encoded cas4 in trans. The red and white sections represent, respectively, direct repeats and spacer sequences. The
analogous genes in the Type II systems are labeled and color coded, where Type II-B is Legionella pneumophila and Type II-A Streptococcus thermophilus.
and I-F CRISPR systems of Pseudomonas aeruginosa (Bondy-
Denomy et al., 2013; Pawluk et al., 2014). The development
of single nucleotide polymorphisms in protospacer adjacent
motif (PAM) sequences prevents targeting of phage 2972 by
the Type II-A CRISPR system of Streptococcus thermophilus
DGCC7710 (Sun et al., 2013). In the presence of constant
CRISPR-mediated selective pressure, phage 2972 was found
to accumulate mutations in the genomic regions that were
selectively targeted by the S. thermophilus DGCC7710 CRISPR
system (Paez-Espino et al., 2015).Myoviridae phages which infect
Vibrio cholerae have been found to encode a complete Type I-F
CRISPR system. Acquisition of the system resulted in the ability
to overcome V. cholerae anti-phage responses encoded within a
pathogenicity island (Seed et al., 2013). As more CRISPR-Cas
systems are studied within the Bacteria and Archaea it will be
interesting to see what other resistance mechanisms emerge.
So far applications of CRISPR technologies and studies
aimed at modifying lytic phages seem to be lacking behind the
new-found roles for Cas9-technologies in genome engineering.
Recently however an elegant study involving the above-
mentioned S. thermophilus DGCC7710 and phage 2972 showed
how Cas9-technologies can be used for the study of lytic phages
(Martel and Moineau, 2014). The Cas9 protein encoded within
the Type II-A CRISPR system of S. thermophilus DGCC7710 is
already widely used in genome engineering (Jinek et al., 2012).
Initially point-mutations were introduced into specific regions
of the phage 2972 genome with an extremely high degree of
efficiency. Introduction of a small 2 bp deletion in orf39 led
to a frameshift and successful inactivation of the target gene.
Two further large deletions in orf39 were also possible and as
adjudged by smaller plaque sizes in phage 2972 orf39 mutants
it was concluded that this gene may be important for fitness of
the phage. Of significant interest one of the main concepts to
emerge from the study was the successful deletion of an open
reading frame (orf33) previously shown to be dispensable, and
its replacement with a bacterial gene. The gene introduced was
the lactococcal methyltransferase LladCHIA which was found
to be fully functional following insertion in phage 2972. It was
observed that immunity to restriction via in vivo methylation of
phage DNA was accomplished by phages bearing the introduced
gene (Martel and Moineau, 2014). The prospect of efficient
engineering of lytic phages capable of overcoming restriction-
modification systems of any given host may be of exceptional
use to industries such as phage therapeutics. Innate resistance
to phages is often mediated via restriction–modification and
alleviating this obstacle may allow advances to be made in trying
to find novel phage-derived treatments for bacterial pathogens of
humans, animals, and plants.
Aside from their classical function of providing a protective
mechanistic response to invading genetic elements, non-
canonical roles for CRISPR-Cas systems have been proposed.
The ability to respond to invasive DNA elements such as
plasmids and phage genomes has led to the discovery that stress
responses triggered by disruption of membrane integrity can
lead to activation of CRISPR-Cas systems (Ratner et al., 2015).
Several important observations have delineated environmental
signals that can be utilized by bacteria to regulate the expression
of CRISPR-Cas systems. Transcriptional activation of CRISPR
systems in Salmonella enterica and Escherichia coli can be
mediated by the global DNA binding histone-like nucleoid
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structural protein (H-NS). Under normal circumstances H-NS
represses CRISPR-Cas transcription; however in response to
breaches in the integrity of the cell membrane H-NS becomes
inactivated leading to transcription of the CRISPR-Cas system,
and enabling the bacteria to respond to lethal infection or the
acquisition of selfish genetic elements that can either compromise
the microorganisms competitive ability or threaten the integrity
of the genome (Westra et al., 2010; Medina-Aparicio et al., 2011).
Interestingly, other functional concepts have emerged from
analyzing CRISPR-Cas biology. For the intracellular human
pathogen Francisella novicida, the ability to survive exposure
to potentially lethal insults such as antibiotics, membrane
degradation, or perturbation, and host immunological responses
is essential. Not only does F. novicida have to contend with
cationic antimicrobial peptides, it is also required to have the
ability to survive within the macrophage following phagocytosis
wherein the bacterium needs to escape the phagosome in order to
replicate in the macrophage cytosolic compartment. Intriguingly
the Cas9 protein encoded within the Type II-B CRISPR system
of F. novicida appears to be essential to overcome several
barriers to successful completion of the intracellular lifecycle.
These actions include resistance to the antibiotic polymyxin
B (functionally akin to host cationic antimicrobial peptides),
evasion of toll-like receptor 2 signaling and dampening of the
inflammasome were all found to be reliant on the presence of
a functioning Cas9 protein, tracrRNA and a scaRNA (Sampson
et al., 2014).
THE Campylobacter BACTERIOPHAGE
CARRIER STATE
Analysis of bacteriophages that target Campylobacter spp. has
led to many interesting insights into how they interact with
their bacterial hosts. In some cases, what could be deemed as
typical predator/prey behavior associated with lytic phages is
foregone and is replaced by an equilibrium known as the carrier
state. The nature of the carrier state is such that rather than
committing to lysis the phage population is stably maintained in
association with its host. Unlike temperate phages which commit
to lysogeny and integrate their genomes into that of their host,
Campylobacter phages remain associated as freely-replicating
infective particles which propagate on a small fraction of the
host population (Siringan et al., 2014; Brathwaite et al., 2015).
This phenomenon has precedents in the literature with reports
of bacteriophage carrier states being identified in Shigella
dysenteriae (Li et al., 1961), Brucella abortus (Jones et al., 1962),
Proteus mirabilis (Coetzee and Hawtree, 1962), mycobacteria
(Baess, 1971), and most recently using phage P22 and Salmonella
typhimurium LT2 (Cenens et al., 2013).
KEY CONCEPT 1 | Bacteriophage Carrier State
The carrier state describes mixtures of bacteria and of bacteriophages that
remain associated in a stable equilibrium. Carrier state cultures contain
subpopulations of bacteria that either support bacteriophage replication or are
resistant but can act as continuous founders of the sensitive subpopulation.
Analysis of carrier state cultures of C. jejuni PT14 confirmed
that the phages and bacterial host remain associated in
stable ratios even following serial passage representing multiple
generations. Initial identification of the bacteriophage carrier
state in C. jejuni PT14 arose following studies that were
initiated to monitor the ability of Class III Campylobacter
phages to disperse Campylobacter biofilms (Siringan et al.,
2011). Bacteria recovered from the biofilms were found to
spontaneously produce phage following disruption of the
structure prompting further investigation of the origins of the
phage burst. A combination of PFGE and Southern blot analysis
was used in order to discount the unlikely event that otherwise
virulent bacteriophage had formed lysogens by integration of
Campylobacter phage genomic DNA. Non-integrated phage
genomic DNAs (band size ∼140 kb) were visible on PFGE gels
containing SmaI-digested C. jejuni genomic DNA migrating
alongside undigested C. jejuni DNA. Hybridization of Southern
blots with Campylobacter phage specific probes for CP8 and
CP30A confirmed that the 140 kb bands represented phage DNA
and that the SmaI-fragments arising from bacterial chromosomal
DNA contained no phage-hybridizing DNA sequences. This
approach revealed that the phage genomes were present in
carrier-state cultures as non-integrated genetic elements and
absent from control cultures. In vivo studies showed that the
carrier state bacteria were unable to colonize the poultry gut
following analysis of the caecal contents of experimentally
inoculated chickens (Siringan et al., 2014). Observations of
planktonic growth phase-dependent parameters indicated that
C. jejuni PT14 growing in the presence of bacteriophages CP8
and CP30A showed reduced fitness in vitro. Initially, bacteria
growing during the early-logarithmic growth phase were found
to be non-motile in carrier state cultures compared to non-
carrier state cultures (uninfected controls). Coincident with the
impairment in motility, bacteria isolated from early-logarithmic
growth cultures displayed a vastly reduced ability to adhere to
and infect HCA-7 colonic epithelial cells (Brathwaite et al., 2015).
Transcriptional studies of the carrier state cultures revealed
significant reduction in the expression of the flaA gene encoding
the major flagellin protein of C. jejuni. Instead the carrier state
cultures show increased σ54-dependent expression of the flaB
gene, which encodes for a second normally minor flagellin
protein (Brathwaite et al., 2015). Translation of the alternative
flagellin genes results in proteins with similar amino acid
sequences; it is therefore likely that the change in regulation is
accompanied with other functional changes in the control of
motility.
Campylobacter PHAGE Cas4 PROTEIN
Recently we reported the presence of a conserved Cas4-like
ortholog in the genomes of both Class II and Class III
Campylobacter phages (Hooton and Connerton, 2014). Cas4
proteins are reported as playing a role during the acquisition of
protospacers in Type II-B CRISPR systems. The structural basis
of Cas4 monomer is reliant on the presence of four conserved
cysteines which together provide the basis for formation of a
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4Fe-4S cluster. This structural arrangement often referred to
as an “iron-staple” is exemplified in AddB nuclease of Bacillus
subtilis and RecB nuclease of E. coli. A decameric toroidal
configuration forms the quaternary structure of the protein
which is observed to consist of five Cas4 dimers (Lemak
et al., 2013). The in vitro activity of Cas4 protein isolated
from the archaeon Sulfolobus solfataricus SSO0001 is reported
to be a 5′–3′ single stranded DNA exonuclease. Specifically,
the Cas4 protein was proposed to function in the generation
of protospacer 3′ single stranded DNA ends that have the
potential to undergo recombination with the CRISPR array
(Zhang et al., 2012). Furthermore, the Cas4 protein was also
shown to have the ability to perform ATP-independent DNA
unwinding against single stranded DNA (Lemak et al., 2013).
Recently, it was reported that a Cas4 protein isolated from the
hyperthermophilic archaeon Pyrobaculum calidifontis contained
a 2Fe-2S cluster (Lemak et al., 2014). In the case of 4Fe-4S Cas4
proteins the four conserved cysteines are absolutely required
for maintaining structural integrity of the iron sulfur cluster
and activity of the protein (Zhang et al., 2012). For 2Fe-2S
Cas4, the nuclease function of the protein was found to remain
intact following mutation of these residues, even though the iron
sulfur cluster was lost (Lemak et al., 2014). Various nuclease
domains/motifs are present in Cas4 proteins including RecB-like
nuclease domains, PD(D/E)XK nuclease domain, and a QXXXY
motif. In silico analysis of Cas4-like proteins in Campylobacter
phages showed that all the domains and motifs described above
are present. The conserved cysteine residues were found to
be intact and even though very little amino acid homology is
observed between intervening sequences in other Campylobacter
phages, the core nuclease domains are also present. Analysis
of phylogenetic trees drawn using Cas4 primary sequence data
for several prokaryotes and Campylobacter phages highlighted
the relatedness between their respective proteins. The addition
of a phage-encoded Cas4 protein into the apparatus of the
C. jejuni PT14 Type II-C CRISPR system (Cas1, Cas2, Cas9,
and tracrRNA) creates a putative system that phenotypically
resembles Type II-B CRISPR systems. Prior to analysis it could
be hypothesized that if the carrier state was to function in a
manner that allowed the survival of phages and their bacterial
hosts then the host CRISPR system must be in some way
inactive, or functioning in an atypical fashion. By combining
the deep sequencing strategies of whole genome sequencing
and RNA-Seq it was possible to identify rare molecular
events which took place during carrier state associations
between C. jejuni PT14 and Campylobacter phages CP8 and
CP30A.
A phylogenetic tree drawn from the alignment of amino
acid sequences of Class II and Class III Campylobacter phage
Cas4-like proteins with a diverse selection of bacterial and
archael Cas4 proteins is shown in Figure 2. The Campylobacter
phages are found to cluster together based on their genome
size such that Class II (170–190 kb) and Class III (110–150 kb)
phages have their own branches. C. coli phages Cpt10 and
vBCcoM-IBB_35 are also observed to cluster on their own sub-
branch of the Class II lineage. A selection of Campylobacter
FIGURE 2 | Phylogenetic analysis of the Cas4 protein family related to the proteins encoded in class II and III Campylobacter bacteriophages using a
neighbor-joining tree methodology (ClustalW2 alignment and FigTree v1.4.2.).
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spp. Cas4 proteins were included in the analysis in order to
evaluate if the Campylobacter phage-encoded Cas4 protein
originated within the bacterial genus. Analysis of aligned amino
acid sequences shows that conservation between phage and
bacterial Cas4 protein appears restricted to the conserved
cysteine residues and nuclease domains found within the
proteins.
KEY CONCEPT 2 | Phage-encoded Cas4 nuclease
Cas4 proteins have a functional role in the protospacer acquisition of Type II-B
CRISPR systems. An analogous role for a phage-encoded Cas4 could confer
a phage activated CRISPR immunity and/or autoimmunity in host bacteria with
alternative Type II CRISPR systems.
C. jejuni Spacer Acquisition
The unexpected finding of a Cas4-like protein in Campylobacter
phages prompted us to analyze the CRISPR array of C. jejuni
PT14 specifically during carrier state infections. Bioinformatic
analysis of Cas4-like proteins of Class II and III Campylobacter
phages showed they were conserved throughout, and the proteins
all bore the hallmarks of Cas4 proteins. For the analysis two well
characterized phages that were identified as encoding a Cas4-
like protein (Class III Campylobacter phages CP8 and CP30A)
were selected on the basis of their ability to establish carrier
state cultures with C. jejuni PT14, and that the host CRISPR
array did not already feature spacers directed at these phages
(Siringan et al., 2014; Brathwaite et al., 2015). However, evidence
suggests that it is possible to acquire spacer sequences directed at
the genomes of the phages CP8 and CP30A since corresponding
spacer DNA sequences have been noted in CRISPR arrays of
C. jejuni genomes deposited in public databases (Pearson et al.,
2015). Using these two phages it was possible to observe de
novo spacer acquisition but the spacers consisted solely of host-
derived sequences. In the absence of phages CP8 or CP30A no
alterations were observed in the C. jejuni PT14 CRISPR array
with the native self-derived spacers remaining fixed.
KEY CONCEPT 3 | Activated self-spacer acquisition
If the CRISPR array can fix host spacer sequences then the interference
mechanism can target the host genome itself resulting in cell death, a situation
termed CRISPR-mediated autoimmunity.
To try to gain an understanding of the impact of carrier
state infection upon C. jejuni PT14 an in-depth molecular
analysis of the Type II-C CRISPR array was performed.
Encoded upstream of the gene moe2 (A911_07320) in C.
jejuni PT14—Acc. No. CP003831 (Brathwaite et al., 2013) is a
CRISPR array containing four 36 bp direct repeats with three
intervening 30 bp spacer sequences. Analysis of the whole
genome sequence of C. jejuni PT14 revealed that the 30 bp
spacers found within the CRISPR array were representative of
self-genes, rather than the expected plasmid or phage sequences.
Intriguingly two of the spacers have homology with genes that are
associated with externally presented proteins—peptidoglycan-
associated lipoprotein Omp18 (18/30 nucleotides—A911_00540)
and apolipoprotein N-acyltransferase (16/30 nucleotides—
A911_05300). Analysis of RNA-Seq reads for these sequences
indicated that apolipoprotein N-acyltransferase is transcribed
at very low levels in C. jejuni PT14. This may allow the
bacterium to evade immunological detection by toll like receptor
2 (TLR2) specifically by down-regulating the production of
stimulatory acylated lipoproteins. Further spacer sequences
were identified which matched the sequences of an isoleucyl
tRNA synthetase (15/30 nucleotides—A911_05135), and a
di/tripeptide transporter (12/30 nucleotides—A911_03195). The
acquisition of spacer sequences of host-origin in carrier state
cultures was found to be in stark contrast to the fixed nature of
the C. jejuni PT14 CRISPR array. For CP8 carrier state cultures
two of the spacers acquired showed complete matches to genes
which are associated with motility and capsular polysaccharide
biosynthesis. The motility-associated spacer was found to target
the gene encoding the motility-associated protein PseE (30/30
nucleotides—A911_06495) which may have some bearing on
the lack of motility observed in C. jejuni PT14 carrier state
cultures. Loss of invasion and adherence capabilities of carrier
state cultures may also be influenced by acquisition of the spacer
targeting the capsular polysaccharide biosynthesis gene (30/30
nucleotides—A911_06909). A similar scenario was observed for
CP30A carrier state cultures in which several different spacers
were observed to target genes exclusively of host origin with
perfect or near-perfect matches to the C. jejuni PT14 genome.
The most notable acquisition was multiple spacers targeting the
genes ADP-heptose-lipooligosaccharide-heptosyltransferase I
and II.
The terminal direct repeat of the CRISPR array is positioned
144 bp upstream of the genes cas2 (A911_07325), cas1
(A911_07330), and cas9 (A911_07335) which are accompanied
by tracrRNA. The generation of pre-crRNAs occurs via
transcription from a −10 transcriptional start site (5′-
TAAAAAT-3′) located 116 bp upstream of the CRISPR
array. Independent promoters with similarity to extended −10
transcriptional start sites (5′-GGTAAAAAT-3′) are also found
preceding each direct repeat. A hallmark of Type II CRISPR
systems is the co-ordination of endogenous RNase III/tracrRNA
during processing to produce mature crRNAs during the
biogenesis step (Deltcheva et al., 2011; Dugar et al., 2013)
Transcriptomic analysis of early exponential phase C. jejuni
PT14 carrier state cultures showed that several genes associated
with RNA biogenesis and RNA processing are differentially
upregulated including RNase III (Brathwaite et al., 2015).
Small RNAs
Differences in the expression of non-coding RNAs were evident
in the carrier state cultures compared to wild type C. jejuni
PT14, most notably the accumulation of sRNAs. RNA-seq
analysis identified sRNAs with heterogeneity at their termini
implying they were generated by RNase processing or perhaps
KEY CONCEPT 4 | Small RNA effectors of carrier state gene expression
Antisense sRNAs have the potential to bind phage or host transcripts and act
as trans-encoded inhibitory RNAs to suppress gene expression.
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mis-processing. For example, PT14CP30 carrier state cultures
contained an over-represented sRNA mapping to an intergenic
genomic sequence between tRNAs (A911_t08346–A911_t08348),
and exhibiting a 40/51 bp match to the CP30 phage genome.
Association between complementary regions of bacterial and
phage RNAs could lead to the preservation of the paired regions
and exoribonuclease processing of the unpaired ends leading to
the observed terminal heterogeneity. Other antisense sRNAs of
chromosomal origin have the potential to bind phage transcripts
(>25 nucleotide sequence matches) and act as trans-encoded
inhibitory RNAs to suppress phage expression. Duplex RNA
structures would also require cleavage by RNase III. Carrier state
cultures exhibit a coordinate increase in the transcription of
genes encoding ribosomal proteins that would also require an
increase in RNase III to process rRNAs for the formation of
ribosomes (Brathwaite et al., 2015). However, increased levels of
RNase III in the carrier state cultures could lead to dysregulation
of any regulatory RNAs that have the potential to fine tune
regulation in a species that is noted for its minimal quota of
regulatory genes. Non-coding RNAs CJnc10, CJnc60, CJnc160,
and CJnc170 reported for C. jejuni NCTC11168 (Dugar et al.,
2013) were conserved in C. jejuni PT14 but of these CJnc10 and
CJnc170 RNAs were all but absent in the carrier state cultures.
CJnc10 and CJnc170 were recently reported to be expressed
from σ28 promoters and to effect translation of σ54-dependent
transcripts through conserved complementary sequences in their
5′ untranslated regions (Le et al., 2015).
FUTURE PERSPECTIVES
The consequences of expressing a phage-encoded Cas4-like
protein in C. jejuni are intriguing and merit further study.
The proposed role of Cas4-like protein as a mediator of
the incorporation of host-derived CRISPR spacers would
require controlled gene expression to suppress CRISPR-mediated
autoimmunity. However, we note that Figure 2 contains
alternative Campylobacter species in the second major clade
that carry cas4-like coding sequences. These are also subject to
modifications in genomic content, for example Campylobacter
fetus subsp. fetus features a CRISPR array but this is partially
deleted in C. fetus subsp. venerealis (Ali et al., 2012). The
relationships between CRISPR-cas related functions of the genus
will require further functional analysis.
The intricate relationship between Campylobacters and their
associated bacteriophage has resulted in insurance mechanisms
that allow for long-term replicative success of predator and
prey. Short-term effects such as transient bacterial resistance
to virulent phage infection following Mu prophage-driven
genomic rearrangements may skew the replication bias toward
the bacterium (Scott et al., 2007), albeit with a reduction in
poultry colonization potential. However, restoration to phage
sensitivity allows the wildtype population to recolonize poultry
at the expected levels. In the carrier state virulent bacteriophage
replication is accommodated whilst a subpopulation of
bacteria remain resistant. The carrier state bacteria themselves
are poor colonizers of poultry but are able to deliver
bacteriophage to sensitive pre-colonized inhabitants (Siringan
et al., 2014). Population level studies of bacteriophage/host
interactions may shed yet further light on the nature of the
success of Campylobacter as a major zoonotic foodborne
pathogen.
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